Author Archives: admin

For some types of cancer, such as chronic myelogenous leukemia (also known as CML), most people with that cancer will have a target for a certain drug, so they can be treated with that drug. But most of the time, your tumor will need to be tested to see if it contains targets for which there is a drug. Testing your cancer for targets that could help choose your treatment is called biomarker testing

BUCK: Control of the United States Senate may well rest with whether our next guest is able to come out victorious in his quest to be the next senator from the state of Pennsylvania. Dr. Mehmet Oz is with us now.

WE'RE told many things when it comes to food: dont skip meals, but skip snacks, eat intuitively, but not too much It can all get very confusing! So its easy to see how the simplicity of intermittent fasting where, sticking to your usual calorie intake, you restrict eating to certain times of the day can seem attractive. 2 Even more so if youre keen to lose weight, which lots of us are this summer saw a whopping 1,100% increase in Google searches for: How to lose stubborn belly fat

Aging is a part of life that we can't do anything about, but we can slow it down or speed it up depending on our lifestyle choices and health habits. In addition to prematurely aging, certain health issues can arise causing the process to accelerate and Eat This, Not That! Health spoke with experts who share signs you're aging faster than you should that you need to be aware of

The dynamics of the complicated urinary tract infection market are anticipated to change in the coming years owing to the improvement in the rise in the number of healthcare spending across the world and rising cases of complicated urinary tract infection.

Wilmington, Delaware, United States, Transparency Market Research Inc. Triple-negative breast cancer (TNBC) doesnt have estrogen or progesterone receptors and also doesnt make too much of the HER2 protein

- Company to host Key Opinion Leader webinar today, September 12, at 1:30 pm CT/2:30 pm ET - LYON, France and CAMBRIDGE, Mass., Sept. 12, 2022 (GLOBE NEWSWIRE) -- Amolyt Pharma, a global company specialized in developing therapeutic peptides for rare endocrine and related diseases, today announced positive efficacy and safety data from the first cohort of its ongoing Phase 2a study of AZP-3601 in patients with hypoparathyroidism at the American Society for Bone and Mineral Research 2022 Annual Meeting (ASBMR), which is being held September 9-12 in Austin, TX.